GSK Investigational Site [clinicaltrials_resource:e58b416c3f6a4ddc10d8daf635a67caa]
clinicaltrials:NCT0007300812-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome [clinicaltrials:NCT00373542]clinicaltrials:NCT00382993clinicaltrials:NCT00633217Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00676052]clinicaltrials:NCT00748098clinicaltrials:NCT00984659clinicaltrials:NCT01313637clinicaltrials:NCT01316913clinicaltrials:NCT01323621clinicaltrials:NCT01323660clinicaltrials:NCT01772134clinicaltrials:NCT01817764clinicaltrials:NCT01868009Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). [clinicaltrials:NCT01957150]clinicaltrials:NCT01957163
location [clinicaltrials_vocabulary:location]
GSK Investigational Site [clinicaltrials_resource:e58b416c3f6a4ddc10d8daf635a67caa]
Bio2RDF identifier
e58b416c3f6a4ddc10d8daf635a67caa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e58b416c3f6a4ddc10d8daf635a67caa
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:e58b416c3f6a4ddc10d8daf635a67caa
title
GSK Investigational Site
@en
type
label
GSK Investigational Site [clinicaltrials_resource:e58b416c3f6a4ddc10d8daf635a67caa]
@en